BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 26747525)

  • 1. IL-10 and integrin signaling pathways are associated with head and neck cancer progression.
    Bornstein S; Schmidt M; Choonoo G; Levin T; Gray J; Thomas CR; Wong M; McWeeney S
    BMC Genomics; 2016 Jan; 17():38. PubMed ID: 26747525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of TESTIN and its association with cancer history and a tendency toward poor survival in head and neck squamous cell carcinoma.
    Gunduz E; Gunduz M; Beder L; Nagatsuka H; Fukushima K; Sutcu R; Delibas N; Yamanaka N; Shimizu K; Nagai N
    Arch Otolaryngol Head Neck Surg; 2009 Mar; 135(3):254-60. PubMed ID: 19289703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptome sequencing uncovers novel long noncoding and small nucleolar RNAs dysregulated in head and neck squamous cell carcinoma.
    Zou AE; Ku J; Honda TK; Yu V; Kuo SZ; Zheng H; Xuan Y; Saad MA; Hinton A; Brumund KT; Lin JH; Wang-Rodriguez J; Ongkeko WM
    RNA; 2015 Jun; 21(6):1122-34. PubMed ID: 25904139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53, p21 and p27 protein expression in head and neck cancer and their prognostic value.
    Kapranos N; Stathopoulos GP; Manolopoulos L; Kokka E; Papadimitriou C; Bibas A; Yiotakis J; Adamopoulos G
    Anticancer Res; 2001; 21(1B):521-8. PubMed ID: 11299798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. H19-DMR allele-specific methylation analysis reveals epigenetic heterogeneity of CTCF binding site 6 but not of site 5 in head-and-neck carcinomas: a pilot case-control analysis.
    De Castro Valente Esteves LI; De Karla Cervigne N; Do Carmo Javaroni A; Magrin J; Kowalski LP; Rainho CA; Rogatto SR
    Int J Mol Med; 2006 Feb; 17(2):397-404. PubMed ID: 16391843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and significance of cancer testis antigens in primary mucosal melanoma of the head and neck.
    Prasad ML; Jungbluth AA; Patel SG; Iversen K; Hoshaw-Woodard S; Busam KJ
    Head Neck; 2004 Dec; 26(12):1053-7. PubMed ID: 15515159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression of activin receptor-like kinase 1 among patients with head and neck cancer.
    Chien CY; Chuang HC; Chen CH; Fang FM; Chen WC; Huang CC; Huang HY
    Otolaryngol Head Neck Surg; 2013 Jun; 148(6):965-73. PubMed ID: 23447486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methylation in the CTCF-binding site I and the expression pattern of the H19 gene: does positive expression predict poor prognosis in early stage head and neck carcinomas?
    Esteves LI; Javaroni AC; Nishimoto IN; Magrin J; Squire JA; Kowalski LP; Rainho CA; Rogatto SR
    Mol Carcinog; 2005 Oct; 44(2):102-10. PubMed ID: 16015666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinoma.
    Chung CH; Parker JS; Ely K; Carter J; Yi Y; Murphy BA; Ang KK; El-Naggar AK; Zanation AM; Cmelak AJ; Levy S; Slebos RJ; Yarbrough WG
    Cancer Res; 2006 Aug; 66(16):8210-8. PubMed ID: 16912200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topoisomerase II alpha expression in squamous cell carcinomas of the head and neck.
    Stathopoulos GP; Kapranos N; Manolopoulos L; Papadimitriou C; Adamopoulos G
    Anticancer Res; 2000; 20(1A):177-82. PubMed ID: 10769652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of the microenvironment of head and neck cancers on tumor progression].
    Lukits J
    Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of telomerase expression in peripheral blood mononuclear cells of head and neck cancer patients.
    Lee BJ; Wang SG; Choi JS; Lee JC; Goh EK; Kim MG
    Am J Clin Oncol; 2006 Apr; 29(2):163-7. PubMed ID: 16601436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma.
    Hama T; Yuza Y; Saito Y; O-uchi J; Kondo S; Okabe M; Yamada H; Kato T; Moriyama H; Kurihara S; Urashima M
    Oncologist; 2009 Sep; 14(9):900-8. PubMed ID: 19726454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of gene promoter methylation in squamous cell cancer of the head and neck.
    Hasegawa M; Nelson HH; Peters E; Ringstrom E; Posner M; Kelsey KT
    Oncogene; 2002 Jun; 21(27):4231-6. PubMed ID: 12082610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of a hypoxia metagene derived from head and neck cancer to prognosis of multiple cancers.
    Winter SC; Buffa FM; Silva P; Miller C; Valentine HR; Turley H; Shah KA; Cox GJ; Corbridge RJ; Homer JJ; Musgrove B; Slevin N; Sloan P; Price P; West CM; Harris AL
    Cancer Res; 2007 Apr; 67(7):3441-9. PubMed ID: 17409455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amplification of the 3q26.3 locus is associated with progression to invasive cancer and is a negative prognostic factor in head and neck squamous cell carcinomas.
    Singh B; Stoffel A; Gogineni S; Poluri A; Pfister DG; Shaha AR; Pathak A; Bosl G; Cordon-Cardo C; Shah JP; Rao PH
    Am J Pathol; 2002 Aug; 161(2):365-71. PubMed ID: 12163360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas.
    Chung CH; Ely K; McGavran L; Varella-Garcia M; Parker J; Parker N; Jarrett C; Carter J; Murphy BA; Netterville J; Burkey BB; Sinard R; Cmelak A; Levy S; Yarbrough WG; Slebos RJ; Hirsch FR
    J Clin Oncol; 2006 Sep; 24(25):4170-6. PubMed ID: 16943533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased dosage and amplification of the focal adhesion kinase gene in human cancer cells.
    Agochiya M; Brunton VG; Owens DW; Parkinson EK; Paraskeva C; Keith WN; Frame MC
    Oncogene; 1999 Oct; 18(41):5646-53. PubMed ID: 10523844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of mutations within the TP53 gene in patients with squamous cell carcinoma of the head and neck].
    Golusinski P; Lamperska K; Pazdrowski J; Golusinski W
    Otolaryngol Pol; 2011; 65(2):114-21. PubMed ID: 21735667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck.
    Brennan JA; Boyle JO; Koch WM; Goodman SN; Hruban RH; Eby YJ; Couch MJ; Forastiere AA; Sidransky D
    N Engl J Med; 1995 Mar; 332(11):712-7. PubMed ID: 7854378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.